Navigation Links
Inhaled Nitric Oxide Data Presented at European Academy of Pediatrics Meeting
Date:10/25/2008

CLINTON, N.J., Oct. 25 /PRNewswire/ -- Ikaria Holdings, Inc. today announced that results from its Phase III clinical trial -- INOT27, nitric oxide for inhalation for the treatment of bronchopulmonary disease (BPD) in premature babies -- were presented at the European Academy of Pediatrics in Nice, France. The pre-specified primary endpoint, survival without BPD, did not meet statistical significance, with the INOT27 treatment group achieving a 65.3% success rate compared to a 65.5% success rate for the control group (p=0.73).

BPD most commonly occurs in pre-term (less than 30 weeks of gestational age) infants with birth weights less than 1,500 g. BPD is even more pronounced in very pre-term infants (less than 26 weeks of gestational age) with birth weights less than 1,000 g. and who have been treated for respiratory distress syndrome.

"These results were quite unexpected based on prior evidence indicating the efficacy of inhaled nitric oxide in the prevention of BPD in pre-term infants," stated lead researcher Jean-Christophe Mercier, MD, MSci, Professor of Pediatrics, University of Paris -- Denis Diderot Medical School and Associate Professor, Division of Pediatric and Neonatal Intensive Care, Hopital Robert Debre, Paris. "Although the study was well designed, a lower dose was administered to higher birth weight infants than in previous studies which -- combined with certain risk-factors of the patient population -- may have contributed to these results. We hope that further research will demonstrate the potential of nitric oxide to improve outcomes for pre-term infants."

The multi-center, double-blind, controlled Phase III clinical trial, examined 800, pre-term infants ranging in gestational age from 24 weeks to 28 weeks, 6 days. All patients required the use of surfactant within 24 hours of birth or the use of CPAP, or continuous positive airway pressure, to maintain an oxygen saturation value of greater than or equal to 85 percent. U
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
2. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
3. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
4. Inhaled Steriods Used as Preventive Treatment Post 9/11
5. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
6. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
7. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
8. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
9. Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
10. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
11. National Study Presented at ACG 2008 Confirms New Device Functions Like Rear-View Mirror to Provide Improved View of the Colon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... company developing its Symphony® CGM System as a ... that Robert F. Doman , Executive Chairman ... at "TEN", Noble Financial Capital Markets, Tenth Annual ... make a corporate presentation to prospective corporate partners ...
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ... price of $2.92 per share, net to the seller ...
(Date:1/14/2014)... 14, 2014 HeartWare International, Inc ... innovator of less invasive, miniaturized circulatory support technologies ... failure, today announced that it expects revenues for ... $53 million, bringing expected full-year 2013 revenues to ... growth of 87% for 2013 above 2012 reflects ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... Perrigo Company (Nasdaq: PRGO ; TASE) today announced ... fiscal 2010 on Monday, November 2, 2009 at approximately 8:00 ... at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo,s ... be available live via webcast to interested parties on the ...
... As previously announced, WebMD Health Corp. (Nasdaq: WBMD ) ... Annual Meetings of Stockholders beginning at 9:30 a.m. Eastern Time on ... of the meetings will be available over the Internet. To listen ... www.wbmd.com (in the Investor Relations section) or at ...
Cached Medicine Technology:WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders 2
(Date:4/14/2014)... April 14, 2014 Popular web information on ... to read and doesn,t address the appropriate risks to ... Medical Center gastroenterologists suggests. , In a review of ... education materials for colorectal cancer screening were written beyond ... sites failed to address key risks, as well as ...
(Date:4/14/2014)... FRANCISCO, Calif.--True North Therapeutics, Inc., announced today a ... the destruction of human red blood cells exposed ... of autoimmune hemolytic anemia (AIHA). The article entitled ... prevents complement activation induced by cold agglutinin disease ... Blood earlier this month. TNT003 is ...
(Date:4/14/2014)... Frank Porter Graham Child Development Institute have released ... program to prepare four-year-olds for success in kindergarten. ... Pre-K show significant gains across all areas of ... even greater rate during their participation in NC ... senior scientist Ellen Peisner-Feinberg, who leads the FPG ...
(Date:4/14/2014)... Ohio Heart patients with beliefs about health that ... skip sessions of cardiac rehabilitation, new research suggests. , ... of these beliefs referred to as "irrational health ... was associated with lower adherence to a prescribed cardiac ... Doubting the preventive power of the flu vaccine or ...
(Date:4/14/2014)... high-risk bladder cancer, chemotherapy before or after surgery ... The findings are published early online in ... Cancer Society. , Clinical trials have shown that ... cancer who are given chemotherapy before surgery. There ... also improves survival. To investigate the use of ...
Breaking Medicine News(10 mins):Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3
... Ontario (CHEO )researcher has found that children and babies are ... fact that generation subsists on cod liver oil, ... has persisted in too many children in Canada. ... stunts growth, the disease can cause painful bone deformities. Very ...
... has shown that regular vaccination of infants against H. ... Hib pneumonia and meningitis, could save innumerable children in ... is published online in The Pediatric Infectious Disease Journal, ... Hib conjugate vaccine prevented more than one-third of acute ...
... focused on cognitive skills may improve child behaviour. ... of the New York Academy of Sciences children who ... consideration of their own and others' emotions were found ... emotional problems. ,The study showed that ...
... to afflict humans very early, not sparing even tiny tots. Children ... in New South Wales in Australia. ,Anxiety disorders ... Macquarie University's Anxiety Research Unit show. ,In children aged ... compared to a rate of about 1 per cent for mood ...
... one bacterial species into another by swapping their genomes, a ... bugs, a pioneer on genetics said Thursday. ... genome, said a team of his researchers had transplanted the ... related species. ,The experiment marks the most ambitious ...
... in movie 'Hairspray', is happy the female costumes he wore helped ... having to wear a fat suit, dress, and high heels to ... iconic musical-turned-movie was the perfect combination to shed the pounds. ... of weight to carry around," Contactmusic quotes him as saying. ...
Cached Medicine News:Health News:Vitamin D Deficiency Still Persists in Babies 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 3Health News:Cognitive Skills Focused Curriculum may Lessen Kids' Behavioural Problems 2Health News:Anxiety Disorders Show in Tiny Tots 2Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 2Health News:Replacing a Genome Boosts Race to Develop Designer Bugs: Study 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: